Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Colorcon
Medtronic
Moodys
Express Scripts

Last Updated: May 19, 2022

FIBRICOR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Fibricor, and what generic alternatives are available?

Fibricor is a drug marketed by Athena and is included in one NDA. There are four patents protecting this drug.

The generic ingredient in FIBRICOR is fenofibric acid. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the fenofibric acid profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Fibricor

A generic version of FIBRICOR was approved as fenofibric acid by ANCHEN PHARMS on July 18th, 2013.

  Try it Free

Drug patent expirations by year for FIBRICOR
Drug Prices for FIBRICOR

See drug prices for FIBRICOR

Recent Clinical Trials for FIBRICOR

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Mutual Pharmaceutical Company, Inc.Phase 1

See all FIBRICOR clinical trials

US Patents and Regulatory Information for FIBRICOR

FIBRICOR is protected by seven US patents.

Patents protecting FIBRICOR

Methods of use of fenofibric acid
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: ADJUNCTIVE THERAPY TO DIET IN PATIENTS WITH HYPERLIPIDEMIAS

Methods of use of fenofibric acid
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: ADJUNCTIVE THERAPY TO DIET TO PATIENTS WITH HYPERTRIGLYCERIDEMIA

Methods of use of fenofibric acid
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: ADJUNCTIVE THERAPY TO DIET IN PATIENTS WITH MIXED DYSLIPIDEMIA

Methods of use of fenofibric acid
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: ADJUNCTIVE THERAPY TO DIET IN PATIENTS WITH ELEVATED CHOLESTEROL AND/OR LIPID LEVELS

Methods of use of fenofibric acid
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: ADJUNCTIVE THERAPY TO DIET IN PATIENTS WITH MIXED DYSLIPIDEMIA

Methods of use of fenofibric acid
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: ADJUNCTIVE THERAPY TO DIET TO PATIENTS WITH HYPERTRIGLYCERIDEMIA

Methods of use of fenofibric acid
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: ADJUNCTIVE THERAPY TO DIET IN PATIENTS WITH HYPERLIPIDEMIAS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Athena FIBRICOR fenofibric acid TABLET;ORAL 022418-001 Aug 14, 2009 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Athena FIBRICOR fenofibric acid TABLET;ORAL 022418-002 Aug 14, 2009 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Athena FIBRICOR fenofibric acid TABLET;ORAL 022418-001 Aug 14, 2009 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Athena FIBRICOR fenofibric acid TABLET;ORAL 022418-001 Aug 14, 2009 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Athena FIBRICOR fenofibric acid TABLET;ORAL 022418-001 Aug 14, 2009 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
AstraZeneca
Express Scripts
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.